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ABSTRACT
The risk of malignant transformation of ex-vivo expanded human mesenchymal 
stromal cells (huMSCs) has been debated in the last years; however, the biosafety of 
these cells after exposure to supramaximal physical and chemical stress has never 
been systematically investigated.
We established an experimental in vitro model to induce supramaximal physical 
(ionizing radiation, IR) and chemical (starvation) stress on ex-vivo expanded bone 
marrow (BM)-derived huMSCs and investigated their propensity to undergo malignant 
transformation. To this aim, we examined MSC morphology, proliferative capacity, 
immune-phenotype, differentiation potential, immunomodulatory properties and 
genetic profile before and after stressor exposure. Furthermore, we investigated the 
cellular mechanisms underlying MSC response to stress. MSCs were isolated from 20 
healthy BM donors and expanded in culture medium supplemented with 5% platelet 
lysate (PL) up to passage 2 (P2). At this stage, MSCs were exposed first to escalating 
doses of IR (30, 100, 200 Gy) and then to starvation culture conditions (1% PL).
With escalating doses of radiation, MSCs lost their typical spindle-shaped 
morphology, their growth rate markedly decreased and eventually stopped (at P4-P6) 
by reaching early senescence. Irradiated and starved MSCs maintained their typical 
immune-phenotype, ability to differentiate into adipocytes/osteoblasts and to inhibit 
mitogen-induced T-cell proliferation. The study of the genetic profile of irradiated/
starved MSCs did not show any alteration. While the induction of supramaximal 
stress triggered production of ROS and activation of DNA damage response pathway 
via multiple mechanisms, our data indicate that irradiated/starved MSCs, although 
presenting altered morphology/growth rate, do not display increased propensity for 
malignant transformation.
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INTRODUCTION
Human mesenchymal stromal cells (MSCs) are 
multipotent cells that can be found in a variety of adult 
tissues, including bone marrow (BM) and adipose tissue 
(AT), besides fetal tissues such as fetal lung and blood 
[1, 2]. The ability to differentiate into mesoderm-derived 
cells, such as adipocytes, chondroblasts, and osteoblasts is 
considered as one of the minimal criteria to define MSCs [3, 
4, 5, 6]. Within the BM, MSCs play a key role in sustaining 
hematopoietic stem cell functions and in regulating the 
production and maturation of hematopoietic progenitors, 
mainly through secretion of paracrine factors [6]. MSCs 
have also been shown to possess broad immune-regulatory 
properties through which they are able to influence both 
adaptive and innate immune responses [7, 8, 9]. Considering 
their fundamental role in immune regulation and in balancing 
tissue homeostasis, MSCs have been administered to patients, 
within experimental phase I-II clinical studies, with the 
aim of repairing tissues and blunting immune responses 
[10, 11, 12]. Based on these initial clinical findings, MSC 
anti-inflammatory therapy is being considered as a novel 
and potentially effective therapeutic option in the rapidly 
evolving field of Regenerative Medicine [13].
For the sake of patient safety, any clinical application 
of MSCs should take into account potential risks, such as 
ectopic tissue formation [14, 15] and tumor generation 
caused by malignant transformation of the cells during ex-
vivo expansion [16]. After initial reports on the occurrence 
of neoplastic transformation in ex-vivo expanded huMSCs 
after long-term culture [16, 17, 18] this event has been 
subsequently described as uncommon, with an estimated 
frequency of <10-9 [19, 20, 21, 22]. Furthermore, neither 
ectopic tissue formation nor MSC-originating tumors have 
ever been reported so far in hundreds of patients treated 
with MSC therapy [23].
To expand the investigation on the biosafety profile of 
ex-vivo expanded MSCs, we have set-up an in vitro model 
aimed at testing their resistance to malignant transformation 
by inducing massive physical and chemical stress. For 
this purpose, we have employed ionizing radiation (IR) in 
combination with deprivation of nutrients as stressors during 
ex-vivo culture of BM-derived MSCs isolated from healthy 
donors (HD-MSCs) and expanded in the presence of a 
GMP-compliant culture medium which also includes platelet 
lysate (PL). Our results indicate that ex-vivo expanded 
huMSCs are resistant to these stressors and are not prone to 
undergo neoplastic transformation even after application of 
supramaximal doses of IR and starvation culture.
RESULTS
Characterization of stressed MSCs
Although being exposed to increasing IR doses, 
MSCs still proved to be able to adhere to plastic surface, 
though they could be replated only for few more 
passages (up to P6). As far as the proliferative capacity 
is concerned, the proliferation rate of stressed MSCs was 
significantly lower in comparison to untreated MSCs, both 
in the presence of 5% PL and after nutrient deprivation. 
Indeed, irradiated MSCs, cultured in the presence of 5% 
PL, showed the following calculated cumulative PDs from 
P1 to P6: untreated MSCs = 11.98 (SD ±0.99); 30 Gy = 
3.79 (SD±1.53); 100 Gy = 3.64 (SD ±1.53); 200 Gy = 3.81 
(SD ±1.48; P<0.001 as compared with untreated MSCs for 
all IR doses; Figure 1A). No significant correlation was 
found between the doses of IR and the inhibitory effect 
on MSC growth rate (P>0.05). The calculated cumulative 
PDs of irradiated and starved MSCs were as follows: 1% 
untreated MSCs = 9.01 (SD ±0.96); 30 Gy = 3.77 (SD 
±1.51); 100 Gy = 3.75 (SD ±1.51); 200 Gy = 3.73 (SD 
±1.49; P<0.001 in comparison to untreated MSCs for all 
IR doses; Figure 1B).
MSC immunophenotype was evaluated by means 
of flow-cytometry after being irradiated and cultured in 
conditions of nutrient deprivation. Stressed MSCs showed 
the typical phenotype [6], which was not altered by the 
induced physical and chemical insults. In particular, as 
shown in Figure 1C, more than 98% of MSCs showed 
negativity for CD33 and positivity for CD13. Moreover, 
stressed MSCs proved to be negative for CD14, CD45, 
CD80 and HLA-DR, and positive for CD73, CD90, 
CD105 and HLA-I (data not shown).
A sharp decrease in MSC proliferation rate, 
progressing to cell-cycle arrest, and the positivity for 
β-Gal staining (Figure 1D) suggested an early replicative 
senescence (at P4-P6) of stressed MSCs, as expected 
after massive IR doses and nutrient deprivation. 
These observations are supported by the stress-related 
morphology alterations in MSCs undergoing IR and 
starvation culture. Furthermore, increasing IR dose 
treatment markedly altered MSC typical spindle-shape 
morphology, which also displayed less regular boundaries, 
in comparison to untreated MSC morphology (Figure 1E). 
Despite these morphology changes, we never revealed, 
even in long-term culture (up to 8 weeks), the presence of 
uncontrolled expanding clones following stress induction.
In order to compare the differentiation potential of 
stressed MSCs with that of untreated MSCs, we induced 
MSC differentiation into osteoblasts and adipocytes 
and evaluated results by histological staining. At any IR 
doses, both irradiated and starved MSCs retained their 
adipocytic differentiation potential, as confirmed by Oil 
Red O positive staining of lipid droplets in cell cultures 
(Figure 2A, right panel and 2D). Although differentiating 
into osteoblasts, irradiated MSCs showed a significantly 
lower ability to form calcium deposits as compared with 
untreated 5% PL-MSCs (P<0.05 for all IR doses), as 
shown by Alizarin Red quantization (see Figure 2B). No 
significant differences were observed between untreated 
and stressed MSCs when cells were cultured with 1% PL.
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IR and starvation culture effect on cell cycle 
progression and cell viability
The effect of ionizing radiation and serum 
deprivation on MSC cell-cycle progression was evaluated 
after stress induction. The fraction of untreated MSCs in 
G0/G1 phase of the cell cycle (during which cells are in 
a quiescent state and are committed to enter cell cycle) 
was 83.7%, whereas the fraction of cells in subG1 phase 
(where apoptotic cells are situated) was 13.6%. As shown 
in Figure 3A, after IR treatment and serum deprivation for 
21 days, the fraction of G0/G1 cells decreased up to 67.9% 
and the subG1 population raised to 28,8% in 200-Gy 
irradiated and starved MSCs. Conversely, after the same 
treatment, the radio-sensible cell line HCC1937 showed a 
marked reduction in G0/G1 cycle progression (15.2%) and 
a consequent increase in subG1 population (up to 70.9%; 
Figure 3B), this confirming the higher resistance of MSCs 
to IR and starvation induced apoptosis.
To investigate whether physical/chemical stressors 
could affect MSC viability, cells were stained with 
propidium iodide and their viability was measured by 
flow-cytometry and compared with that of the radio-
resistant A549 cell line. As shown in Figure 3C-D, MSC 
cell viability decreased from 93.1% (untreated MSCs) to 
89% (200 Gy/starved MSCs), whereas A549 cell viability 
decreased from 90% (untreated A549) to 59.5% (200 
Gy starved A549), thus showing a superior resistance of 
MSCs to irradiation-induced apoptosis as compared with 
a known radio-resistant cell line.
Effect of irradiation and starvation culture on 
MSC immunomodulatory capacity
In order to evaluate whether exposure to IR 
and/or starvation culture conditions could affect the 
immunomodulatory capacity of MSCs, we measured 
the percentage of proliferation of peripheral blood 
Figure 1: Calculated population doublings (PDs) from passage (P)1 to P6 of bone marrow (BM)-derived human 
mesenchymal stromal cells (huMSCs) exposed to ionizing radiation (IR) in the presence of a 5% platelet lysate (PL) 
additioned medium (A) and in starvation conditions (B). MSCs were irradiated with escalating doses (30, 100 and 200 Gy) at P2, 
and then plated with 5% or 1%PL. Starvation culture consisted of alternating 1% PL and 5% PL at each passage. Graphs show the mean of 
three different MSCs samples. After IR exposure, both 5% PL- and 1% PL-cultured MSCs show a marked decrease in their proliferation 
rate. C. Immunophenotype of untreated MSCs and 200 Gy irradiated MSCs from one representative sample, in starvation culture. Both 
untreated and stressed MSCs proved to be negative for CD33 and positive for CD13 surface markers. As shown in the morphological dot 
plot, MSCs became larger and looked exhausted after 200 Gy irradiation. D. ß-Galactosidase staining of MSCs from one representative 
healthy donor (HD) exposed to 30 Gy (left panel) or 200 Gy (right panel) IR and, then, to starvation culture. Senescence of the cells is 
indicated by the positivity for the staining. E. Morphology of culture-expanded MSCs obtained from one representative HD and exposed 
to stressors. Left panel: morphology of untreated MSCs; central panel: morphology of irradiated MSCs in the presence of 5% PL; right 
panel:morphology of irradiated MSCs in the presence of 1% PL. Magnification x5. Black arrows spotlight alterations in MSC morphology.
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mononuclear cells (PBMCs) after stimulation with 
phytohemagglutinin (PHA) either in the presence or in the 
absence of stressed MSCs in an allogeneic setting. While 
in the absence of MSCs, PBMC proliferation to PHA 
was 75.80% (SD ± 28.5), as previously reported [24, 25], 
a marked in vitro inhibitory effect exerted by untreated 
MSCs on the proliferation of PHA-stimulated PBMCs was 
demonstrated: mean percentage of proliferation 4.70% 
(SD ± 2.11; P<0.001 in comparison to PHA+PBMCs 
alone) and 24.58% (SD ± 8.37; P=0.004 in comparison 
to PHA+PBMCs alone) at MSC:PBMC ratios of 1:2 and 
1:10, respectively. MSC capacity to inhibit allogeneic 
PBMC proliferation was unaltered after 30 Gy-irradiation: 
PBMC mean proliferation in the presence of 30 Gy-
irradiated MSCs was 23.23% (SD ± 21.37; P=0.01 in 
comparison to PHA+PBMCs alone) and 30.35% 
(SD ± 26.86; P=0.03 in comparison to PHA+PBMCs 
alone) at ratios 1:2 and 1:10, respectively (Figure 4). 
Superimposable results were achieved when MSCs 
irradiated at higher doses (100 and 200 Gy) were added to 
the co-culture (see Figure 4). Therefore, at any IR dose, the 
inhibitory effect exerted by MSCs on PBMC proliferation 
was maintained and was dependent on MSC:PBMC ratio, 
suggesting that IR does not seem to alter in vitro MSC 
immune-regulatory capacity. When PBMCs were co-
cultured with irradiated and starved MSCs, no statistically 
significant difference between untreated and stressed 
MSCs was revealed at 1:2 MSC:PBMC ratio, whereas the 
inhibitory effect of irradiated and starved MSCs was less 
evident at 1:10 MSC:PBMC ratio (Figure 4).
These data were confirmed by the analysis of 
soluble factors and cytokines in culture supernatants after 
PBMC co-culture. As far as anti-inflammatory cytokines 
are concerned, the co-culture of PBMCs with irradiated 
and starved MSCs resulted in the same secretion pattern 
of the co-culture with untreated huMSCs. In particular, no 
statistically significant difference in IL6, IL10 and TGFβ 
levels was revealed in co-cultures with stressed MSCs, in 
comparison with the conditions PHA+PBMCs+untreated 
MSCs for both MSC:PBMC ratios (see Supplementary 
Figure S1A and S1B). Measurements of the pro-
inflammatory cytokine IFNγ and of some soluble factors 
known to mediate MSC immunomodulating effect (i.e. 
HGF and Galectin-1), were not significantly different 
in supernatants collected from co-cultures of PHA-
stimulated PBMCs and stressed MSCs and in supernatants 
collected from PHA+PBMCs+untreated MSCs co-
cultures. In detail, IFNγ levels diminished also in the 
presence of stressed MSCs, whereas HGF and Galectin-1 
levels increased after exposure to stressed MSCs (see 
Supplementary Figure S2A and S2B). Cytokine and 
soluble factor levels measured in the presence of MSCs 
Figure 2: Histological staining and quantification of the osteogenic and adipogenic differentiation capacity of huMSCs 
isolated from one representative sample before and after irradiation and nutrient deprivation. A. Histological staining 
with Alizarin Red (for osteoblasts, left panel) and Oil Red O (for adipocytes, right panel). B, C. quantification of osteogenic differentiation 
capacity by evaluating the deposits of calcium (positivity for the Alizarin Red staining, B) and the alkaline phosphatase activity (C). 
D. quantification of the differentiation into adipocytes by assessing the amount of Oil Red O stained lipid droplets. The amount of dye is 
related to the amount of DNA extracted from the same wells and is expressed in mOD/μg. Each bar represents the mean +/-SD of three 
experiments. * stands for P<0.05 calculated for the comparison between untreated and irradiated 5% PL MSCs.
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Figure 3: Cell-cycle and cell-viability analysis of untreated and 200 Gy irradiated and starved MSCs. Left panel A, B. 
the picture shows representative FACS analysis of untreated and stressed MSCs (in the presence of 1%PL). As indicated by cell-cycle 
hystograms, after induction of stress, most MSCs remain quiescent in G0/G1 phase (A), whereas the totality of HCC1937 cells, after stress, 
becomes apoptotic (subG1 phase, B). Right panel C, D. cell viability assay indicates a minor percentage of dead cells after induction of 
stress for MSCs (11%, C), whereas a higher percentage of dead cells among radio-resistant A549 cells is shown (41.5%, D). Experiments 
were conducted in triplicate for each condition.
Figure 4: In vitro immunomodulatory effect of untreated and stressed MSCs on PBMC proliferation. The graph shows the 
proliferation of healthy donor PBMCs stimulated with phytohemagglutinin (PHA) either in normal conditions or in starvation conditions. 
Each bar represents the percentage of proliferation of 105 PBMCs, in the presence of two different MSC:PBMC ratios (MSC:PBMC ratio 
of 1:2 and 1:10), calculated by measuring 3H-thymidine incorporation after 3-day co-culture. Grey bars refer to 5% PL-cultured MSCs, 
whereas black bars refer to 1% PL- cultured MSCs. The count per minute (cpm) values at each cell concentration were normalized to the 
cpm of PBMCs without MSCs in each experiment. Each bar represents the mean ± SD of five experiments (each point being in triplicate) 
with MSCs obtained from 5 HDs.
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exposed to 100 and 200 Gy IR showed superimposable 
results (data not shown).
Genetic characterization of stressed MSCs
To assess the potential risk of transformation 
into malignant cells following stress exposure, despite 
phenomena of MSC outgrowth failed to occur, MSC 
genetic profile was characterized by means of array-CGH 
and conventional karyotyping after IR and starvation 
culture.
Array-CGH analyses of irradiated and starved MSCs 
did not reveal any imbalanced chromosomal alteration. 
Indeed, as shown in Figure 5A, no DNA deletion or 
duplication at any irradiating dose (including the condition 
of irradiation with 200 Gy) was detected. Since balanced 
genetic aberrations cannot be detected by array-CGH, in 
order to better define the genetic profile of stressed MSCs, 
the same MSC samples investigated by array-CGH were 
analyzed through conventional karyotyping. By this latter 
assay, chromosomal alterations were not detected in MSCs 
after exposure to IR and starvation culture (Figure 5B). 
It has to be pointed out that, since at very high IR doses 
it was not possible to collect enough metaphases (≥20), 
karyotyping was performed only on 30 Gy-irradiated 
MSCs.
Conversely, the genetic characterization by 
conventional karyotyping of the two control cell lines 
(i.e. A549 and HCC1937) showed many chromosomal 
anomalies and double strand breaks after IR treatment 
[26], even at the lowest irradiation dose of 30 Gy. 
Considering the polyploidy of both cell lines and their 
naturally occurring chromosomal rearrangements, we 
analyzed their genetic profile at the first passage in 
culture, after four passages and after IR treatment. Both 
A549 (although known to be radio-resistant at 16Gy) and 
HCC1937 (radio-sensitive) [27, 28] did not accumulate 
chromosomal rearrangements after passaging in culture; 
however, they showed substantial chromosomal breakings 
already after 30 Gy IR exposure (see Supplementary 
Figure S3; at higher IR doses and serum deprivation 
conditions, genetic analysis was not performed due to 
massive cell death and consequent no availability of 
sufficient metaphases).
Taken together, these results demonstrate that 
MSCs are not prone to develop neoplastic transformation 
after exposure to supramaximal physical and chemical 
stressors. Neither IR, reported to obstacle DNA synthesis 
and to induce DNA damage, nor nutrients deprivation, 
often present in the tumor hypoxic microenvironment, 
could induce MSC genetic alterations.
Activation of stress-induced DNA damage 
response pathway
Besides cell-cycle arrest with early replicative 
senescence and eventually cell death, exposure to IR is 
known to cause the production of intracellular reactive 
oxygen species (ROS) and to induce single- and double-
strand DNA breaks [29]. In our experimental setting, IR 
treatment induced the increase of ROS-producing cells up 
to 75% (after 200 Gy irradiation and starvation culture), 
resulting in cell injury and DNA damage (see Figure 6A). 
Since it has been shown that a network of damage sensors, 
signal transducer and repair effector molecules mediates 
the response of cells to DNA damage [30], by means of 
immunofluorescence and gene expression analysis, we 
characterized the effects of γ-irradiation and starvation 
Figure 5: Array-CGH profile A. and cytogenetic analysis through conventional karyotype B. of one representative MSC sample 
irradiated at 200 Gy and cultured with nutrients deprivation. Both array-CGH and karyotype were performed on all 20 HD-MSCs. The 
profiles are linear; neither unbalanced chromosomal rearrangements nor chromosomal aberrations were shown.
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culture on a number of key DNA damage response 
pathways in MSCs and in two control cell lines (A549 
and HCC1937, a radio-resistant and a radio-sensitive cell 
line, respectively). By immunofluorescence, we observed 
the phosphorylation of intracellular ataxia telangiectasia 
mutated protein (ATM), a crucial factor responsible for the 
recruitment and activation of multiple downstream DNA 
damage sensing and repair proteins in stressed MSCs 
(Figure 6B). Noteworthy, immunofluorescent staining 
of stressed MSCs showed an increase in the number of 
pATM foci with escalating doses of IR, whereas this effect 
was less evident in irradiated and starved MSCs (data 
not shown). In order to evaluate the role played by DDR 
pathway in MSC resistance to malignant transformation, 
we performed gene expression analysis on cDNA 
samples isolated from untreated and stressed MSCs and 
from the two control cell lines A549 and HCC1937. As 
shown in Figure 6C, the expression of genes known to 
be responsible for the non-homologous end-joining 
(NHEJ) repair of double strand breaks (DSBs), such 
as PRKDC, Rad50, H2AFX and ATM increased in 
MSCs in response to increasing doses of IR. Similarly, 
proteins responsible for the activation of homologous 
recombination (HR) pathway, such as RPA1, BRCA1 
and Rad51, showed a considerable higher expression in 
MSCs after the induction of physical and chemical stress. 
Moreover, as demonstrated by cell-cycle progression 
analysis, after IR and starvation treatment, most MSCs 
stopped at G1 checkpoint, at which cells are ready to enter 
the cell cycle, but did not proceed further this restriction 
point. The decision to undergo a new round of cell 
division normally occurs when cyclin-CDK-dependent 
transcription process is activated, followed by the entry 
into S phase; interestingly, cyclin-CDK-dependent 
CDKN1a gene (coding for p21 protein), constitutively 
expressed in untreated MSCs, became downregulated 
after stress induction, whereas other DNA damage sensors 
involved in cell cycle arrest, such as p53, CHEK1 and 
CHEK2, were found to be more expressed in stressed 
cells, thus confirming the blockade of cell proliferation 
after IR treatment. Finally, genes responsible for cell 
survival/apoptosis switch, i.e. BAK, BCL 2, CASPASE 
3 and 8 and COL11A2 (coding for PARP), resulted to be 
overexpressed after IR and starvation culture. Similar gene 
expression patterns were found in MSCs irradiated in the 
presence of 1%PL, although at a less extent than 5%PL 
Figure 6: Analysis of ROS level and DDR pathway activation after induction of stress. In A. ROS levels were measured 
by flow-cytometry in untreated and 30 Gy irradiated MSCs in the presence of 5%PL. In B. the analysis of DNA-damage induced ATM 
phosphorylation of one representative sample is shown. Both untreated and 200 Gy irradiated MSCs were stained using an anti-phosphoATM 
primary antibody and a FITC-labeled secondary anti-rabbit IgG antibody. DNA was stained using DAPI. Images were captured using a 
Leica DMI8 fluorescence microscope. In C. a heatmap representation of gene expression analysis performed on untreated and stressed 
MSCs, A549 and HCC1937 is shown. 200 Gy irradiated condition is not represented since RNA quality after isolation was not satisfactory. 
Data shown are representative of one MSC donor; similar analyses were performed on 5/20 HD-MSCs with superimposable results.
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cultured cells, this suggesting a minor role played by 
DDR pathway in nutrient deprivation conditions (data not 
shown). As for control cell lines, in radio-resistant A549 
cells a higher expression of DDR responsible genes was 
observed after IR treatment with increasing expression 
in response to escalating IR doses, although at a lower 
extent than stressed MSCs (see Figure 6C). Conversely, 
there was hardly any DDR activation in the stressed radio-
sensible HCC1937 cells.
These data confirm huMSC resistance to IR and 
starvation culture, which may be, at least partly, mediated 
by the activation of DDR pathways in response to 
stressors.
DISCUSSION
The present study provides support to the biosafety 
profile of ex-vivo expanded huMSCs even after exposure 
to supramaximal stress by demonstrating that, despite 
altered morphology and growth rate, MSCs are resistant 
to IR and starvation culture and do not display propensity 
to transform into malignant cells.
Two previous studies have shown that the biological 
and functional profiles of AT- and BM-derived MSCs 
could be altered after long-term in vitro culture, which 
promoted the onset of genetic alterations leading to 
neoplastic transformation [16, 17, 18, 19]. These reports 
have been subsequently retracted and re-interpreted 
in light of the contamination of the MSC cultures by 
tumor cell lines [32, 33]. Moreover, other researchers, 
including our group, have shown that long-term in vitro 
culture of huMSCs can be performed without altering 
their typical phenotypical/functional profile and without 
inducing genetic aberrations [22, 31]. To better delineate 
the genetic profile of BM-derived huMSCs, we employed 
both conventional karyotyping and array-CGH and 
documented the absence of genetic abnormalities in these 
cells after long-term expansion [22, 31]. Altogether, these 
data suggest that malignant transformation is likely to 
be an uncommon event in huMSCs ex vivo expanded in 
standard, plastic-adherent culture conditions and in the 
presence of foetal bovine serum [19].
Starting from this notion, our initial experimental 
plan was to artificially induce, through high-dose IR 
and starvation culture, malignant transformation in our 
MSC culture system, which was based on an animal-
free, PL-based culture medium. This would have had 
potentially allowed us to generate a transformed huMSC 
population to be characterized and studied, in order to 
get insight into mechanisms of malignant transformation 
in ex-vivo cultured huMSCs. Despite the application of 
potent supramaximal stress, we were not able to induce 
malignant transformation in our cells, this confirming that 
huMSCs are not prone to undergo neoplastic changes also 
after application of physical/chemical stressors and under 
ex-vivo culture conditions, which include PL that, due to 
the high content in platelet-derived growth-factors, has 
been reported to induce an intense proliferative drive on 
ex-vivo cultured MSCs [34]. Exposure to IR is known to 
significantly influence viability and proliferative capacity 
of irradiated cells; however, MSCs have been shown to 
be relatively radio-resistant as compared with other BM-
derived stem cells when exposed to a maximal dose of 
12 Gy [35]. To obtain a combined physical-chemical 
stressful environment, we have also employed nutrient 
deprivation, which is known to occur during disease 
processes, such as ischemia and infection [36, 37]. 
While the precise mechanisms underlying MSC distress 
due to serum deprivation remain to be elucidated, it has 
been reported that processes related to caspase-induced 
apoptosis pathway, such as loss of nuclear and membrane 
integrity, chromatin condensation and reduction in cell 
size can be triggered even by a brief (i.e. 24 hours-
treatment) nutrient deprivation. Moreover, re-feeding 
starved cells with growth factors or serum has been 
shown to induce powerful proliferative drive [38, 39]; 
indeed, in our protocol, it was employed to induce further 
cellular stress. Following exposure to this combination of 
stressing agents, we performed a thorough phenotypical, 
functional and genetic characterization of MSCs isolated 
from BM of 20 HDs. Our data demonstrate that, with 
escalating IR doses (up to 200 Gy), MSCs proliferative 
capacity becomes significantly lower in comparison to 
untreated MSCs; these results are in line with a previously 
reported study employing 12 Gy irradiation [40]. Despite 
this reduced proliferation rate, irradiated MSCs were still 
capable of adhering to plastic surface and displayed the 
typical MSC surface markers, this suggesting that MSC 
adhesion properties and phenotype are not affected by 
IR exposure. These observations were confirmed when, 
after IR treatment, MSCs were also cultured in starvation 
conditions. The noticed morphological changes associated 
with IR exposure were less evident when MSCs were 
cultured with nutrient deprivation. This latter finding 
might be explained by the reduced proliferative pressure 
induced by the lower concentration of platelet-derived 
growth factors in the starvation culture conditions. 
As regards cell cycle analysis, our results confirm the 
blockade of cell cycle progression induced in MSCs by IR 
and serum deprivation, without triggering apoptosis and 
cell death. Moreover, no statistically significant difference 
was observed between untreated and irradiated MSCs in 
their immunomodulatory effect; only after starvation/re-
feeding culture, a reduction in MSC inhibitory capacity 
was observed at 1:10 MSC:PBMC ratio, this possibly 
reflecting the exhaustion of some primitive MSC functions 
when the level of stress exceeds a certain limit. A similar 
observation can be made when considering the reduced 
ability to form Alizarin Red-positive calcium deposits in 
irradiated and starved MSCs, especially at the higher IR 
doses. The genetic characterization indicates that MSCs 
are not prone to undergo transformation after exposure 
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to IR; moreover, also the lack of nutrients followed by 
re-feeding did not seem to trigger the development of 
genetic abnormalities. Our data indicate that MSC radio-
resistance, already reported at much lower IR doses [41, 
42], seems to be maintained at supramaximal doses of 
radiation and after starvation culture.
In order to investigate the mechanisms of MSC 
resistance to supramaximal stress, we evaluated some 
of fundamental mechanisms underpinning cell defense 
against radiation and, in particular, the role of DDR 
pathway [30]. Since IR exerts its effects mostly on cell 
genomic information, either by directly depositing its 
energy onto DNA molecules or by creating free radicals 
that, in turn, interact with the DNA strands, we first 
investigated and demonstrated the intracellular activation 
of ATM [43], a central regulatory protein of DDR pathway, 
which binds to sites of DNA breaks and is responsible 
for phosphorylation of various downstream components, 
including Chk2 protein and the histone variant H2AX. 
Noteworthy, the level of ATM activation, measured by 
counting pATM foci, increased in response to escalating 
IR doses. While base damage or single-strand breaks occur 
much more frequently, DNA double strand breaks are 
considered the main toxic lesion by which IR kills cells. 
Swift recognition and repair of DNA damage is crucial for 
affected cells; failure to repair may result in cell death and 
misrepairing may lead to an accumulation of mutations 
and genomic instability. Based on these considerations, 
we decided to perform an in-depth evaluation of the 
mechanisms responsible for MSC resistance to stressors 
and consequent maintenance of genomic stability. Gene 
expression analysis on stressed MSCs indicated a strong 
induction of NHEJ-related proteins (such as Rad51, ATM, 
H2AFX, XRCC5 and ERCC6), as well as the activation 
of HR pathway-dependent molecules (such as RPA1 and 
BRCA1) in response to high IR doses. Additionally, we 
demonstrated that IR-induced damage can trigger the 
activation of the DNA damage response, as shown by the 
activation of p53, that subsequently promote the delay 
or even the arrest of cell-cycle, in order to allow DNA 
repair before the cell cycle progresses [44, 45]. Moreover, 
as previously described [46], our study indicates that 
MSC radio-resistance is at least partly mediated by the 
equilibrium between the levels of pro-apoptotic and anti-
apoptotic proteins (as shown by the strong induction of 
BCL2 and MYC).
In conclusion, our study suggests that exposure to 
massive doses of IR and deprivation of nutrients affects 
MSC morphology and proliferation rate by inducing 
early replicative senescence; however, it does not alter 
the phenotypical and functional properties of MSCs and 
it does not influence their genetic stability. Moreover, 
we showed that the activation of DDR pathway in MSCs 
undergoing supramaximal stress may contribute to prevent 
their oncogenic transformation. In view of the broader 
use of MSCs in the clinical arena, our data indicate that 
low-dose irradiation might be employed to abolish MSC 
proliferation before infusion, without compromising their 
immunomodulatory activity. Finally, data obtained through 
our in vitro stress model may be employed by Regulatory 
Authorities with the aim to support the safe employment 
of ex vivo expanded huMSCs in PL-supplemented medium 
and may serve as a prototype system to study stem cell 
aging in stressing conditions.
MATERIALS AND METHODS
MSC isolation and ex-vivo expansion
After obtaining written informed consent, MSCs 
were isolated from residual cells of 20 HDs (median age 
16 years, range 5-32) who donated BM for hematopoietic 
stem cell transplantation at Bambino Gesù Children’s 
Hospital, Rome, Italy. Mononuclear cells were isolated 
by density gradient centrifugation (Ficoll 1.077 
g/ml; Lympholyte, Cedarlane Laboratories Ltd., The 
Netherlands) and plated in non-coated 75-175 cm2 
tissue culture flasks (BD Falcon, NJ, USA) at a density 
of 160000/cm2 in complete culture medium: DMEM 
(Euroclone, Milan, Italy) supplemented with 5% PL, 
50 U/ml penicillin, 50 mg/ml streptomycin and 2 mM 
L-glutamine (Euroclone). PL was prepared as previously 
described [34]; expired platelet apheresis were obtained 
from 10 healthy volunteers at the Transfusion Service of 
our Hospital and were previously screened for infectious 
agents according to Italian legislation. PL preparations 
obtained from the different donors were pooled in a single 
culture supplement to be used for the generation and 
expansion of MSCs. Cultures were maintained at 37°C 
in a humidified atmosphere, containing 5% CO2. After 
48-hour adhesion, non-adherent cells were removed and 
culture proceeded with culture medium being replaced 
twice a week. MSCs were harvested, after reaching 
≥80% confluence, using Trypsin (Euroclone), and were 
propagated at 4000 cells/cm2 up to P2.
Irradiation and nutrient starvation
Once they had reached P2 in culture, MSCs were 
detached and exposed to escalating doses of γ-rays (30, 100 
and 200 Gy) by means of Gamma Cell 1000 Elite irradiator 
(Nordion International, CDN). Following irradiation, 
nine out of the 20 MSC samples were also cultured in 
the presence of 1% PL-supplemented medium at 4000 
cells/cm2. In this second cohort of MSC samples, at each 
passage, 1% PL- and 5% PL- supplemented media were 
alternated, in order to stress cells in starvation/refeeding 
culture conditions. After trypsinization, cells were harvested 
and characterized for proliferative capacity, phenotype, 
functional properties and genetic profile and compared 
with untreated MSCs. Cultures were maintained at 37°C 
in a humidified atmosphere, containing 5% CO2, and after 
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expansion they were exposed to escalating doses of γ–rays 
(30, 100 and 200 Gy) and then to serum deprivation culture, 
as previously described for MSCs. A549 cell line (a human 
hypotriploid Non-Small Cell Lung Carcinoma, NSCLC, 
cell line) and HCC1937 (a primary ductal breast carcinoma 
cell line with a modal number of 100 chromosomes) were 
obtained from ATCC (LGC Standards, Middlesex, UK) 
and cultured following manufacturer’s instructions; cell 
lines were employed as radio-resistant and radio-sensitive 
control cell line, respectively, and were submitted to the 
same treatment of MSCs.
Characterization of stressed MSCs
Proliferative capacity
Cell growth was analyzed by direct cell counts, 
and population doublings (PDs) were determined at each 
passage. The number of PDs was calculated for each MSC 
sample by using the formula log10(N)/log10(2) where N 
means cells harvested/cells seeded; results were expressed 
as cumulative PDs from passage P1 to P6 [47].
Immune-phenotype
MSCs were phenotypically characterized by means 
of direct immunofluorescence with a FACSCanto flow-
cytometer (BD PharMingen, San Diego, CA). Fluorescein 
isothiocyanate (FITC)- or phycoerythrin (PE)-conjugated 
monoclonal antibodies specific for CD13, CD14, CD34, 
CD45, CD73, CD80, CD90, class I-HLA and HLA-DR, 
CD73, CD105 (BD PharMingen) were used. Appropriate, 
isotype-matched, non-reactive fluorochrome-conjugated 
antibodies were employed as controls. Analysis of cell 
populations was performed and data were calculated using 
the FACSDiva software (Tree Star, Inc. Ashland, OR).
Senescence assay
After exposure to IR and starvation, senescence of 
MSCs was evaluated by direct-light microscopy and by 
staining with a senescence β-galactosidase (SA-β-gal) 
Staining Kit (Cell Signaling Technology, Danvers, MA), 
according to manufacturer’s instructions.
Cell cycle and viability analyses
For cell cycle, after IR and starvation culture, cells 
were fixed in ice-cold 70% ethanol and incubated for 30 
min at 37°C with a PBS solution containing 20 μg/ml 
propidium iodide and 100 μg/ml RNAse (BD Biosciences). 
Cell-cycle progression was analyzed by flow-cytometry 
using a FACSCanto flow-cytometer (BD PharMingen). 
Cell viability was assessed by staining cells with 10 μg/
ml Propidium Iodide Solution (BD Biosciences). Both 
assays were analyzed using the FACSDiva software (BD 
PharMingen).
Differentiation capacity
The osteogenic differentiation capacity of MSCs 
was assessed at P3 both for stressed and untreated MSCs 
by incubating cells with αMEM (Euroclone), 5% PL, 
50 U/ml penicillin, 50 mg/ml streptomycin, and 2 mM 
L-glutamine supplemented with 10-7M dexamethasone 
and 50 mg/ml L-ascorbic acid; starting from day +7 of 
the culture, 5 mM ß-glycerol phosphate (Sigma-Aldrich, 
St Louis, MO) was added to the medium. Adipogenic 
differentiation was evaluated at P3 both for stressed and 
untreated MSCs by incubating cells with αMEM, 5% PL, 
50 U/ml penicillin, 50 mg/ml streptomycin, and 2 mM 
L-glutamine supplemented with 10-7M dexamethasone, 
50 mg/ml L-ascorbic acid, 100 mg/ml insulin, 50 
mM isobutyl methylxanthine, 0,5 mM indomethacin 
(Sigma-Aldrich) and 5 mM b-glycerol phosphate. Both 
osteogenic and adipogenic cultures were incubated for 
at least two weeks before differentiation was evaluated. 
To detect osteogenic differentiation, cells were stained 
for alkaline phosphatase (AP) activity using Fast Blue 
(Sigma-Aldrich) and for calcium deposition with Alizarin 
Red (Sigma-Aldrich). Adipogenic differentiation was 
evaluated through the morphological appearance of fat 
droplets stained with Oil Red O (Sigma-Aldrich). AP, 
Alizalin Red and Oil Red O extraction were measured 
spectrophotometrically at 550nm and compared 
to a standard titration curve for quantification of 
osteogenic and adipogenic differentiation, as previously 
described [48].
PBMC proliferation assay with PHA
PBMCs were obtained by conventional Ficoll 
separation from heparinized peripheral blood samples 
from 10 HDs who gave informed consent for participation 
to this study; cells were employed on the same day of 
collection. The proliferation of PBMCs in RPMI 1640 
medium (Gibco, Life Technologies Ltd, CA) supplemented 
with 10% FBS, in response to phytohemagglutinin 
(PHA-P; Sigma-Aldrich), either in the presence or 
absence of BM-derived MSCs, before and after exposure 
to physical/chemical stressors, was performed in triplicate 
in flat-bottom 96-well tissue culture plates (BD Falcon, 
Franklin Lakes, NJ). Briefly, MSCs were seeded at 
MSC:PBMC ratios of 1:2 and 1:10 per well and allowed to 
adhere overnight before adding 105 PBMCs per well with 
or without PHA (5 μg/ml). After 3-day incubation at 37°C 
in a humidified 5% CO2 atmosphere, cultures were pulsed 
with 3H-thymidine (1 μCi/well, specific activity 6.7 Ci/
mmol, Perkin Elmer, Waltham, MA) and harvested after 
18 hours. 3H-thymidine incorporation was measured by 
standard procedure with Microbeta Trilux 1450 instrument 
(Perkin Elmer); results were expressed as percentage of 
proliferation. All the experiments were performed in an 
allogeneic setting.
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Genetic profile of stressed MSCs
Molecular karyotyping on stressed MSCs 
was performed through array-comparative genomic 
hybridization (array-CGH) with the Agilent kit (Human 
Genome CGH Microarray, Agilent Technologies, Santa 
Clara, CA) on each of the 20 HDs. The array-CGH 
platform is a 60-mer oligonucleotide-based microarray 
that allows a genome-wide survey and molecular 
profiling of genomic aberrations with a resolution of 
about 41 kb (kit 60K). DNA was extracted from MSCs 
with QIAamp® DNA Blood Kit (QIAGEN) according 
to the manufacturer’s instructions. DNA (1 μg) from 
stressed MSCs and unstressed MSCs, as controls, of the 
same sex (control DNA, Promega, Madison, WI) were 
processed according to the reported protocol (Agilent 
Oligonucleotide Array-Based CGH for Genomic DNA 
Analysis – Version 6.2.1, February 2010). The array was 
analyzed through the Agilent Scanner and the Feature 
Extraction software (v10.7.3.1) and Agilent Genomic 
Workbench Lite Edition 6.5.0.18.
Stressed MSCs were also analyzed by conventional 
karyotyping. Before harvesting, MSCs at P6 were 
incubated at 37°C with colcemid (IrvineScientific, Santa 
Ana, CA) at 1 μg/ml final concentration for 5 hours. 
Then, cells were fixed and spread according to standard 
procedures. Metaphases of cells were GTG-banded and 
karyotyped in accordance with the International System 
for Human Cytogenetic Nomenclature recommendations 
(ISCN, 2009). At least 20 metaphases were analyzed for 
each sample.
Conventional karyotyping was also performed on 
the control cell lines (A549 and HCC1937) before and 
after irradiation at 30 Gy.
Analysis of DNA damage response pathway
Gene expression analysis
The effects of γ-irradiation and starvation culture 
on gene expression of MSCs (three different samples) and 
two control cell lines (A549 and HCC1937) were assessed 
using custom Taqman® array 96-well Fast plates (Applied 
Biosystems, Life Technologies), previously designed to 
measure the expression level of genes involved in DDR 
pathway and cell cycle (47 target genes plus 1 endogenous 
control, in duplicate). Briefly, after irradiation and starvation 
culture, RNA was isolated with TRIzol (Life Technologies) 
followed by phenol-chloroform extraction and reverse 
transcription. Then, 25 ng of cDNA per well of each sample 
were plated in custom array plates (each well corresponding 
to one gene assay) and quantitative real-time PCR was 
performed by means of Quantstudio 12K Flex instrument 
(Life Technologies). Data were analyzed with Quantstudio 
Analysis software (Applied Biosystem). Statistical analysis 
was performed using paired Student’s t-test.
Immunofluorescence staining
Both untreated and irradiated/starved MSCs were 
plated on culture slides (BD Falcon). After fixation in 4% 
paraformaldehyde for 20 minutes, permeabilization with 
0.1% SDS for 10 minutes and blocking with 3% bovine 
serum albumin for 20 minutes, cells were incubated with 
anti-ATM rabbit monoclonal antibody (phospho S1981; 
Abcam, Cambridge, UK) for 14 hours at 4°C followed 
by incubation with goat anti-rabbit polyclonal Alexa 
Fluor 488 antibody (Abcam) for 1 hour at 37°C. Nuclei 
were subsequently stained with Hoechst nucleic acid 
stain (Molecular Probes, Life Technologies). Cells were 
finally mounted with 3% glycerol solution and observed 
under a fluorescence microscope (Leica DMI8) with 40x 
magnification. The number of phospho-ATM foci was 
determined using ImageJ software.
Detection of ROS by flow-cytometry
ROS levels were measured by CellROX® Green 
Flow Cytometry assay kit (Molecular Probes, Life 
Technologies Ltd). Briefly, after IR and starvation culture, 
cells were incubated for 30 minutes at 37°C with 1μm 
CellROX® Green reagent and with 5μm of SYTOX® Red 
Dead Cell Stain. Then, samples were analyzed by flow-
cytometry, using 488-nm excitation for the CellROX® 
Green reagent and 639-nm excitation for the SYTOX® Red 
stain at FACSCanto flow-cytometer (BD PharMingen); 
results were analyzed with FACSDiva Software.
Statistical analysis
Comparisons on the equality of means of PDs 
were performed by using the Student’s t-test, assuming 
paired data. The two-sample test of proportion was used 
to compare data expressed in percentages (PHA-induced 
PBMC proliferation). For both tests, a p-value lower than 
0.05 was considered to be significant. Statistical analysis 
was performed using the Stata/IC 11.0 software package. 
Data were analyzed in April, 2016.
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